The Possibilities of Assessing the Quality of Life in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD) in children are chronic immune-mediated conditions that significantly affect the quality of life (QOL). QOL assessment tools designed specifically for children allow us to quantify the degree of the disease’s impact on various aspects of their lives, such as daily activity, emotional state, social interactions, etc. The research results demonstrate that IBD has a negative impact on children’s QOL, leading to lower school performance, limited social activity, and psychological problems such as anxiety and depression. The severity of the disease, the frequency of exacerbations, the presence of symptoms, extra-intestinal manifestations, the need to follow a diet, frequent hospitalization, and side effects of drug therapy are factors associated with lower QOL. Improving QOL is one of the key goals of treatment, along with achieving clinical and endoscopic remission. Interventions aimed at improving QOL in children with IBD include pharmacological therapy, nutritional support, and psychosocial care. Regular QOL assessment allows doctors and parents to better understand the child’s needs, identify problem areas, and develop customized strategies aimed not only at controlling the disease, but also at improving overall well-being. The article summarizes data on existing methods for assessing QOL in pediatrics, including in the pathology of the gastrointestinal tract and, in particular, in IBD.

1. Cohen AB, Lee D, Long MD, et al. Dietary patterns and selfreported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013;58(5):1322–1328. doi: https://doi.org/10.1007/S10620-012-2373-3

2. Guadagnoli L, Mutlu EA, Doerfler B, et al. Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. Qual Life Res. 2019;28(8):2195–2205. doi: https://doi.org/10.1007/s11136-019-02170-4

3. Wils P, Caron B, D’Amico F, et al. Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge.j Clin Med. 2022;11(15):4269. doi: https://doi.org/10.3390/jcm11154269

4. Chouliaras G, Margoni D, Dimakou K, et al. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol. 2017;23(6):1067–1075. doi: https://doi.org/10.3748/wjg.v23.i6.1067

5. Khavkin AI, Nalyotov AV, Marchenko NA. Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2023;33(6):7–15. (In Russ). doi: https://doi.org/10.22416/1382-4376-2023-33-6-7-15

6. Health promotion glossary. World Health Organization (WHO); Division of Health Promotion, Health Education and Communication (HPR). Geneve: WHO; 1998. 36 p. (In Russ).] Доступно по: https://iris.who.int/bitstream/handle/10665/64546/WHO_HPR_HEP_98.1_rus.pdf. Ссылка активна на 27.05.2025.

7. Khomyakov EA, Pikunov DYu, Mamedli ZZ, et al. Validation and adaptation of the Russian version colostomy impact score (CIS). Koloproktologia. 2023;22(3):112–120. (In Russ). doi: https://doi.org/10.33878/2073-7556-2023-22-3-112-120

8. Aivazyan SA. Integral indicators of the quality of life of the population: their construction and use in socio-economic management and inter-regional comparisons. Moscow: Central Economic Mathematical Institute of the RAS; 2000. 117 p. (In Russ).

9. Eremyan ZA, Shchelkova OYu. The history of the formation and development of the concept of quality of life in medicine. Psihologiya. Psihofiziologiya = Psychology. Psychophysiology. 2022;15(1):37–49. (In Russ). doi: https://doi.org/10.14529/jpps220104]

10. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54. doi: https://doi.org/10.1186/1477-7525-1-54

11. Makarova EV, Krysanov IS, Vasilyeva TP, et al. Ways to assess the quality of life in children with orphan diseases. Problemi socialnoi gigieni, zdravookhranenia i istorii meditsini. 2020;28(Special Issue):778–784. (In Russ). doi: https://doi.org/10.32687/0869-866X-2020-28-s1-778-784

12. Yarlas A, Bayliss M, Cappelleri JC, et al. Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review. Qual Life Res. 2018;27(2):273–290. doi: https://doi.org/10.1007/s11136-017-1690-6

13. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.j Clin Epidemiol. 1993;46(12):1417–1432. doi: https://doi.org/10.1016/0895-4356(93)90142-n

14. Kadam P, Bhalerao S. Sample size calculation. Int J Ayurveda Res. 2010;1(1):55–57. doi: https://doi.org/10.4103/09747788.59946

15. Suponeva NA, Melnik EA, Arestova AS, et al. Validation Chronic Acquired Polyneuropathy – Patient Reported Index (CAP-PRI) in Russia for CIDP patients. Neuromuscular Diseases. 2022;12(3):17–25. (In Russ). doi: https://doi.org/10.17650/22228721-2022-12-3-17-25

16. Guidelines for Best Practice in Cross-Cultural Surveys. 2016. 842 p. Available online: https://ccsg.isr.umich.edu/wp-content/ uploads/2019/06/CCSG_Full_Guidelines_2016_Version.pdf. Accessed on May 27, 2025.

17. Nikitina TP, Ionova TI. Modern issues of quality of life research in pediatrics. Pediatric Bulletin of the South Ural. 2022;(1):4–18. (In Russ). doi: https://doi.org/10.34710/Chel.2022.94.65.002

18. Surkov AN, Chernikov VV, Baranov AA, et al. Results of Life Quality Evaluation in Children with Hepatic Variant of Glycogen Disease. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2013;10(4):90–94. (In Russ). doi: https://doi.org/10.15690/pf.v10i4.759

19. Petersen S, Hagglof B, Stenlund H, Bergstrom E. Psychometric properties of the Swedish Peds QL. Acta Paediatr. 2009;98(9):1504– 1512. doi: https://doi.org/10.1111/j.1651-2227.2009.01360.x

20. Denisova RV, Alekseeva EI, Al’bicky VYu, et al. Reliability, Validity and Sensitivity of Russian Versions of the PedsQL Generic Core Scale and PedsQL Rheumatology Module Questionnaires. Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(1):30–40. (In Russ).

21. Vinayrskaya IV, Tshernikov VV, Terletskaya RN, Soboleva KA. Development and validation of the Russian version of HUI questionnaire in pediatrics. Social Aspects of Population Health (Scientific e-journal). 2015;(2):1–13. (In Russ).

22. Mardiyan MA, Mkrtchyan SA, Chopikyan AS, Dunamalyan RA. Otsenka kachestva zhizni detei shkol’nogo vozrasta pri LOR-patologii s pomoshch’yu SF-36 mezhdunarodnogo oprosnika. In: Luchshaya nauchnaya stat’ya 2016: A collection of articles by the winners of the IV international scientific and practical competition, Penza, November 30, 2016. Penza: Nauka i Prosveshchenie; 2016. pp. 370–374. (In Russ).

23. Jamolova RJ, Mukhabbatov DK, Rakhmonov DT, Ali-Zade SG. Komplaentnost’ i kachestvo zhizni bol’nykh s vospalitel’nymi zabolevaniyami kishechnika = Compliance and quality of life of patients with inflammatory bowel diseases. Vestnik Avitsenny = Avicenna Bulletin. 2024;26(1):76–85. (In Russ). doi: https://doi.org/10.25005/2074-0581-2024-26-1-76-85

24. Matos R, Lencastre L, Rocha V, et al. Quality of life in patients with inflammatory bowel disease: the role of positive psychological factors. Health Psychol Behav Med. 2021;9(1):989–1005. doi: https://doi.org/10.1080/21642850.2021.2007098

25. Knowles SR, Graff LA, Wilding H, et al. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Metaanalyses-Part I. Inflamm Bowel Dis. 2018;24(4):742–751. doi: https://doi.org/10.1093/ibd/izx100

26. Knowles SR, Keefer L, Wilding H, et al. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Metaanalyses-Part II. Inflamm Bowel Dis. 2018;24(5):966–976. doi: https://doi.org/10.1093/ibd/izy015

27. Ilich M, Shchelkova OYu. Kachestvo zhizni patsientov s vospalitel’nymi zabolevaniyami kishechnika. In: Aktual’nye problemy klinicheskoi psikhologii i praktika ikh resheniya: Materials of the All-Russian scientific and practical conference, Rostov-onDon, November 23–24, 2023. Moscow: Kredo; 2023. pp. 188–194. (In Russ).

28. Kulygina YuA, Osipenko MF. Quality of Life in Patients with Inflammatory Bowel Diseases and Irritable Bowel Syndrome: What Is Common? Effektivnaya farmakoterapiya. 2023;19(8):50–54. (In Russ). doi: https://doi.org/10.33978/2307-3586-2023-19-8-50-54

29. Gainullina GR, Kirillova ER, Odintsova AKh, Abdulganieva DI. Relationship between damage to joints and entheses and quality of life in patients with inflammatory bowel diseases. Practical medicine. 2024;22(4):87–93. (In Russ). doi: https://doi.org/10.32000/2072-1757-2024-4-87-93

30. Bisgaard TH, Allin KH, Keefer L, et al. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. 2022;19(11):717–726. doi: https://doi.org/10.1038/s41575-022-00634-6

31. Araki M, Shinzaki S, Yamada T, et al. Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study. PLoS One. 2020;15(5):e0233365. doi: https://doi.org/10.1371/journal.pone.0233365

32. Fracas E, Costantino A, Vecchi M, Buoli M. Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences? Int J Environ Res Public Health. 2023;20(13):6255. doi: https://doi.org/10.3390/ ijerph20136255

33. Yuan X, Chen B, Duan Z, et al. Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics. Gut Microbes. 2021;13(1):1987779. doi: https://doi.org/10.1080/19490976.2021

34. Bolotova EV, Yumukyan KA, Dudnikova AV. Comparative assessment of the quality of life and the level of anxiety and depression in patients with ulcerative colitis. Doctor.Ru. 2023;22(2):51–56. (In Russ). doi: https://doi.org/10.31550/17272378-2023-22-2-51-56

35. Vogels T, Verrips GH, Verloove-Vanhorick SP, et al. Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res. 1998;7(5):457–465. doi: https://doi.org/10.1023/a:1008848218806

36. Zyuzina DS, Mikhaylichenko TG, Ilich M. The Relationship of Emotional State to Coping Strategies and Personality Resources in Patients with Infammatory Bowel Disease. The Bulletin of Psychotherapy. 2024;(91):72–85. (In Russ). doi: https://doi.org/10.25016/2782-652X-2024-0-91-72-85

37. Zargar A, Gooraji SA, Keshavarzi B, Haji Aghamohammadi AA. Effect of Irritable Bowel Syndrome on Sleep Quality and Quality of Life of Inflammatory Bowel Disease in Clinical Remission. Int J Prev Med. 2019;10:10. doi: https://doi.org/10.4103/ijpvm.IJPVM_364_17

38. Havkin AI, Novikova VP, Naletov AV, et al. Analysis quality of life of Crohn’s disease patients based on the sf-36 questionnaire. Experimental and Clinical Gastroenterology. 2024;(1):92–98. (In Russ). doi: https://doi.org/10.31146/1682-8658-ecg-221-1-92-98

39. Bandel VE, Mikhailova EI. Mental health and quality of life in patients with ulcerative colitis. Health and Ecology Issues. 2021;18(3):42–46. (In Russ). doi: https://doi.org/10.51523/2708-6011.2021-183-5

40. Mendonça CM, Correa Neto IJF, Rolim AS, Robles L. Inflammatory Bowel Diseases: Characteristics, Evolution, and Quality of Life. Arq Bras Cir Dig. 2022;35:e1653. doi: https://doi.org/10.1590/0102672020210002e1653

41. Khan S, Sebastian SA, Parmar MP, et al. Factors influencing the quality of life in inflammatory bowel disease: A comprehensive review. Dis Mon. 2024;70(1S):101672. doi: https://doi.org/10.1016/j.disamonth.2023.101672

42. Kim S, Park S, Kang Y, et al. Medical staff tend to underestimate the quality of life in children and adolescents with inflammatory bowel disease. Acta Paediatr. 2019;108(1):138–142. doi: https://doi.org/10.1111/apa.14498

43. Silonyan AL, Surkov AN, Chernikov VV. The quality of life of children with inflammatory bowel diseases. Russian Pediatric Journal. 2021;24(Suppl):55–56. (In Russ). doi: https://doi.org/10.46563/1560-9561-2021-24-S

44. Tagirova AR. Kachestvo zhizni u detei s vospalitel’nymi zabolevaniyami kishechnika. [abstract of dissertation]. Moscow; 2021. 25 p. (In Russ).

45. De Carlo C, Bramuzzo M, Canaletti C, et al. The Role of Distress and Pain Catastrophizing on the Health-related Quality of Life of Children with Inflammatory Bowel Disease.j Pediatr Gastroenterol Nutr. 2019;69(4):e99–e104. doi: https://doi.org/10.1097/MPG.0000000000002447

46. Vekara L, Kantanen S, Kolho KL, et al. Psychological well-being of children and adolescents with inflammatory bowel disease.j Pediatr Gastroenterol Nutr. 2024;78(6):1287–1296. doi: https://doi.org/10.1002/jpn3.12220

47. Bramuzzo M, De Carlo C, Arrigo S, et al. Parental Psychological Factors and Quality of Life of Children With Inflammatory Bowel Disease.j Pediatr Gastroenterol Nutr. 2020;70(2):211–217. doi: https://doi.org/10.1097/MPG.0000000000002548

48. Calviño-Suárez C, Ferreiro-Iglesias R, Bastón-Rey I, Barreirode Acosta M. Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment. Int J Environ Res Public Health. 2021;18(13):7159. doi: https://doi.org/10.3390/ijerph18137159

49. Scheffers LE, Vos IK, Utens EMWJ, et al. Physical Training and Healthy Diet Improved Bowel Symptoms, Quality of Life, and Fatigue in Children with Inflammatory Bowel Disease.j Pediatr Gastroenterol Nutr. 2023;77(2):214–221. doi: https://doi.org/10.1097/MPG.0000000000003816

50. Khavkin AI, Nikolaychuk KM, Lukichev DA, et al. Assessment of the quality of life of patients with inflammatory bowel diseases depending on the drug therapy performed. Experimental and Clinical Gastroenterology. 2024;(8):258–272. (In Russ). doi: https://doi.org/10.31146/16828658-ecg-228-8-258-272

51. Zagorskiy SE, with chronic diseases of the upper digestive tract. Pediatric Nutrition. 2013;11(1):30–33. (In Russ).

52. Ioan A, Ionescu MI, Boboc C, et al. Applicability of the PedsQLTM 4.0 Generic and Fatigue Modules in Romanian Children with Inflammatory Bowel Disease: Pilot Study. Maedica (Bucur). 2023;18(4):607–614. doi: https://doi.org/10.26574/maedica.2023.18.4.607

53. Jelenova D, Prasko J, Ociskova M, et al. Quality of life in adolescents with inflammatory bowel disease and their parents--comparison with healthy controls. Neuro Endocrinol Lett. 2015;36(8):787–792.

54. Smyth M, Chan J, Evans K, et al. Cross-Sectional Analysis of Quality of Life in Pediatric Patients with Inflammatory Bowel Disease in British Columbia, Canada.j Pediatr. 2021;238:57–65.e2. doi: https://doi.org/10.1016/j.jpeds.2021.07.036

55. Polivanova TV, Kasparov EV, Vshivkov VA. Quality of life indicators for schoolchildren with abdominal pain. Experimental and Clinical Gastroenterology . 2023;1(1):158–164. (In Russ). doi: https://doi.org/10.31146/1682-8658-ecg-209-1-158-164

56. Polivanova TV, Kasparov EV, Vshivkov VA. The impact of gastroesophageal reflux disease on the quality of life of children and adolescents in the Republic of Tyva. Sibirskij nauchnyj medicinskij zhurnal = Siberian Scientific Medical Journal. 2024;44(5):172–180. (In Russ). doi: https://doi.org/10.18699/SSMJ20240520]

57. Rychkova SV. Kachestvo zhizni detei shkol’nogo vozrasta i vliyanie na nego khronicheskoi gastroduodenal’noi patologii. [abstract of dissertation]. St. Petersburg; 2009. 46 p. (In Russ).

58. Parra-Izquierdo V, Frías-Ordoñez JS, Márquez JR, et al. Healthrelated quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study. Rev Gastroenterol Peru. 2023;43(2):95–103.

59. Dubinsky M, Rice A, Yarlas A, et al. Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators. Inflamm Bowel Dis. 2024;30(11):2115– 2126. doi: https://doi.org/10.1093/ibd/izad282

60. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn’s Relapse Prevention Trial Study Group. Gastroenterology. 1994;106(2):287–296. doi: https://doi.org/10.1016/0016-5085(94)90585-1

61. Shaimerdenov ShD. Otsenka kachestva zhizni patsientov s bolezn’yu Krona i nespetsificheskim yazvennym kolitom posle primeneniya biologicheskoi (antitsitokinovoi) terapii s ispol’zovaniem oprosnika IBDQ-32. Young Scientist. 2019;(22):255–260. (In Russ).doi: https://moluch.ru/archive/260/59749/

62. Wilburn J, McKenna SP, Twiss J, et al. Assessing quality of life in Crohn’s disease: development and validation of the Crohn’s Life Impact Questionnaire (CLIQ). Qual Life Res. 2015;24(9):2279– 2288. doi: https://doi.org/10.1007/s11136-015-0947-1

63. Adegbola SO, Dibley L, Sahnan K, et al. Development and initial psychometric validation of a patient-reported outcome measure for Crohn’s perianal fistula: The Crohn’s Anal Fistula Quality of Life (CAF-QoL) Scale. Gut. 2021;70(9):1649–1656. doi: https://doi.org/10.1136/gutjnl-2019-320553

64. McDermott E, Keegan D, Byrne K, et al. The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients.j Crohns Mel’nov SB. Dynamics of quality of life in children and adolescents Colitis. 2013;7(8):616–621. doi: https://doi.org/10.1016/j.crohns.2012.07.030

65. Park SK, Ko BM, Goong HJ, et al. Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease. World J Gastroenterol. 2017;23(19):3530– 3537. doi: https://doi.org/10.3748/wjg.v23.i19.3530

66. Otley A, Smith C, Nicholas D, et al. The IMPACT questionnaire: A valid measure of health-related quality of life in pediatric inflammatory bowel disease.j Pediatr Gastroenterol Nutr. 2002;35(4):557–563. doi: https://doi.org/10.1097/00005176-200210000-00018

67. Chen XL, Zhong LH, Wen Y, et al. Inflammatory Bowel DiseaseSpecific Health-Related Quality of Life Instruments: A Systematic Review of Measurement Properties. Health Qual. Life Outcomes. 2017;15(1):177. doi: https://doi.org/10.1186/s12955-017-0753-2

68. Abdovic S, Mocic Pavic A, Milosevic M, et al. The IMPACT-III (HR) questionnaire: a valid measure of health-related quality of life in Croatian children with inflammatory bowel disease.j Crohns Colitis. 2013;7(11):908–915. doi: https://doi.org/10.1016/j.crohns.2012.12.010

69. Werner H, Landolt MA, Buehr P, et al. Validation of the IMPACTIII quality of life questionnaire in Swiss children with inflammatory bowel disease.j Crohns Colitis. 2014;8(7):641–648. doi: https://doi.org/10.1016/j.crohns.2013.11.025

70. Lee GW, Chew KS, Wong SY, et al. Quality of life in Malaysian children with inflammatory bowel disease: An understudied population.j Paediatr Child Health. 2022;58(11):1972–1979. doi: https://doi.org/10.1111/jpc.16130

71. Vanhelst J, Béghin L, Drumez E, et al. Validation of the IMPACT-III Questionnaire in French Children With Inflammatory Bowel Disease.j Pediatr Gastroenterol Nutr. 2023;76(4):e71–e76. doi: https://doi.org/10.1097/MPG.0000000000003716

72. Hughes LD, King L, Morgan M, et al. Food-related Quality of Life in Inflammatory Bowel Disease: Development and Validation of a Questionnaire.j Crohns Colitis. 2016;10(2):194–201. doi: https://doi.org/10.1093/ecco-jcc/jjv192

73. Czuber-Dochan W, Morgan M, Hughes LD, et al. Perceptions and psychosocial impact of food, nutrition, eating and drinking in people with inflammatory bowel disease: a qualitative investigation of food-related quality of life.j Hum Nutr Diet. 2020;33(1):115–127. doi: https://doi.org/10.1111/jhn.12668

74. Whelan K, Murrells T, Morgan M, et al. Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients. Am J Clin Nutr. 2021;113(4):832– 844. doi: https://doi.org/10.1093/ajcn/nqaa395

75. Brown SC, Whelan K, Frampton C, et al. Food-Related Quality of Life in Children and Adolescents with Crohn’s Disease. Inflamm Bowel Dis. 2022;28(12):1838–1843. doi: https://doi.org/10.1093/ibd/izac010

76. Abdovic S, Pavic AM, Milosevic M, et al. Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(4):818–823. doi: https://doi.org/10.1097/MIB.0000000000000324

77. Varni JW, Kay MT, Limbers CA, et al. PedsQL gastrointestinal symptoms module item development: qualitative methods.j Pediatr Gastroenterol Nutr. 2012;54(5):664–671. doi: https://doi.org/10.1097/MPG.0b013e31823c9b88

78. Varni JW, Bendo CB, Denham J, et al. PedsQL gastrointestinal symptoms module: feasibility, reliability, and validity.j Pediatr Gastroenterol Nutr. 2014;59(3):347–355. doi: https://doi.org/10.1097/MPG.0000000000000414

79. Varni JW, Bendo CB, Shulman RJ, et al. Interpretability of the PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients with Functional and Organic Gastrointestinal Diseases.j Pediatr Psychol. 2015;40(6):591–601. doi: https://doi.org/10.1093/jpepsy/jsv005

80. Bräutigam M, Dellenmark-Blom M, Gatzinsky V, et al. Linguistic and content validity of the Swedish version of the PedsQL™ gastrointestinal symptoms scales and symptoms module for paediatric patients. Acta Paediatr. 2021;110(11):3124–3130. doi: https://doi.org/10.1111/apa.16066

81. Varni JW, Bendo CB, Nurko S, et al. Health-related quality of life in pediatric patients with functional and organic gastrointestinal diseases.j Pediatr. 2015;166(1):85–90. doi: https://doi.org/10.1016/j.jpeds.2014.08.022

82. Vinycomb T, Browning A, Jones MLM, et al. Quality of life outcomes in children born with duodenal atresia.j Pediatr Surg. 2020;55(10):2111–2114. doi: https://doi.org/10.1016/j.jpedsurg.2019.11.017

83. Lu PL, Teich S, Di Lorenzo C, et al. Improvement of quality of life and symptoms after gastric electrical stimulation in children with functional dyspepsia. Neurogastroenterol Motil. 2013;25(7):e567– e456. doi: https://doi.org/10.1111/nmo.12104

84. Joshi S, Parmar S, Kalavant A, et al. Effectiveness of structured physiotherapy in constipation in children with neurodevelopmental disorders-a randomized trial. Physiother Theory Pract. 2024;40(1):2–10. doi: https://doi.org/10.1080/09593985.2022.2100299

85. Baaleman DF, Vriesman MH, Lu PL, et al. Long-Term Outcomes of Antegrade Continence Enemas to Treat Constipation and Fecal Incontinence in Children.j Pediatr Gastroenterol Nutr. 2023;77(2):191–197. doi: https://doi.org/10.1097/MPG.0000000000003833

86. Boon M, Claes I, Havermans T, et al. Assessing gastro-intestinal related quality of life in cystic fibrosis: Validation of PedsQL GI in children and their parents. PLoS One. 2019;14(12):e0225004. doi: https://doi.org/10.1371/journal.pone.0225004

87. Roca M, Masip E, Colombo C, et al. Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis. Arch Dis Child. 2024;109(7):552–556. doi: https://doi.org/10.1136/archdischild-2023-326221

88. Chandrasekar N, Dehlsen K, Leach ST, Krishnan U. Blenderised Tube Feeds vs. Commercial Formula: Which Is Better for GastrostomyFed Children? Nutrients. 2022;14(15):3139. doi: https://doi.org/10.3390/nu14153139

89. Mussies C, Duvoisin G, Le A, et al. Gastric emptying and myoelectrical activity testing in children with esophageal atresia: A pilot study.jPGN Rep. 2023;5(1):10–16. doi: https://doi.org/10.1002/jpr3.12021

90. Saiad MO, Bahre MNI, Ryad N. Quality-of-life Assessment among Children with Esophageal Achalasia.j Indian Assoc Pediatr Surg. 2023;28(6):457–464. doi: https://doi.org/10.4103/jiaps.jiaps_67_23

91. van den Bunder FAIM, Pijpers AGH, van Heurn LWE, et al. Long-term Gastrointestinal Sequelae in Children who Underwent Pyloromyotomy for Infantile Hypertrophic Pyloric Stenosis.j Pediatr Surg. 2024;60(2):162073. doi: https://doi.org/10.1016/j.jpedsurg.2024.162073

92. Varni JW, Franciosi JP, Shulman RJ, et al. PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with inflammatory bowel disease in comparison with healthy controls. Inflamm Bowel Dis. 2015;21(5):1115–1124. doi: https://doi.org/10.1097/MIB.0000000000000351

93. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79. doi: https://doi.org/10.1186/1477-7525-4-79

94. Arakelyan AL, Surkov AN, Baranov AA, et al. Linguistic accuracy and authenticity of the content of the Russian version of the module of gastrointestinal symptoms of the PedsQL™ questionnaire for pediatric patients. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2023;20(2):112–119. (In Russ). https://doi.org/10.15690/pf.v20i2.2553